ASH 2024: Hōʻike ka Hui Lu Daopei i 13 mau holomua noiʻi ma Hematology

Ua hoʻonohonoho ʻia ka Hālāwai Makahiki 66 o ka American Society of Hematology (ASH) e mālama ʻia mai Dekemaba 7 a hiki i ka 10, 2024, ma San Diego, Kaleponi. Ma ke ʻano he hanana nui loa a piha loa i ke kahua o ka hematology, e hōʻike ana ka ʻaha kūkā o kēia makahiki i nā haneli o nā kūkākūkā e pili ana i nā holomua hou, e huki ana i nā hematologists a me nā loea mālama ola ma mua o 27,000 mai nā ʻāina he 100 a ʻoi.

I kēia makahiki, ua loaʻa iā ASH ma mua o 7,000 mau palapala hōʻuluʻulu manaʻo, me kahi kaʻina koho koʻikoʻi e hopena ana i nā mea e hōʻike ana i nā hana hou koʻikoʻi i ka hematology. He leo koʻikoʻi no ka hematology Kina, ua haʻaheo ka hui lapaʻau o ka Halemai ʻo Lu Daopei e hōʻike i 13 mau hoʻokō noiʻi ma ka ʻaha kūkā o kēia makahiki, e hōʻike ana i ko lākou ulu ʻana o ka maikaʻi i ka noiʻi ʻepekema.

Ma waena o nā ʻōlelo pōkole koʻikoʻi he haʻawina e pili ana i ka "Comprehensive Fusion Gene Landscape in B-cell Lymphoblastic Leukemia," i hōʻike ʻia e Kauka Xue Chen, a me kekahi e ʻimi nei i ka "CD7-Targeted CAR-T Cell Therapy," e hōʻike ana i ka pono a me ka palekana i ka mālama ʻana i nā peripheral refractory. Lymphoma T-Cell.

Hoʻopili ka noiʻi i nā kumuhana like ʻole, mai ka hoʻoili ʻana o nā cell kumu hematopoietic a hiki i ka diagnostics laboratory, e hōʻike ana i ka ʻike loea piha a me nā hiki noiʻi hou o ka hui haukapila ʻo Lu Daopei. ʻAʻole wale kā lākou mau haʻawina e hōʻike i ka ikaika pālua o ka hana hou ʻepekema a me ka hana lapaʻau akā hoʻoikaika pū i kā lākou kūpaʻa i ka hoʻolaha ʻana i nā lāʻau lapaʻau no nā maʻi hematological.

I ka hoʻokokoke ʻana mai o ka ʻaha kūkā, ke kakali nei ka hui o ka Halemai ʻo Lu Daopei i ka kaʻana like ʻana i kēia mau ʻike noiʻi me ke kaiāulu hematology honua a e hāʻawi i nā hōʻike kikoʻī ma hope o ka hanana. E noho mālie no nā mea hou aku!